- Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulationHua, Chen; Ma, Qinhai; Zhu, Yun; Xia, Shuai; Liu, Zezhong; Li, Lin; Lu, Lu; Zhong, Nanshan; Liu, Shuwen*; Yang, Zifeng*; Jiang, Shibo*Signal Transduction and Targeted Therapy, 2021, 6(1): 318.被引 7
- Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2Lin, Yifan; Sun, Jing; Cao, Xuezhi; Wang, Xiuye; Chen, Xi; Xu, Hairong; Zhao, Jincun*; Fu, Yang-Xin*; Peng, Hua*Cell Discovery, 2022, 8(1): 43.被引 3
- Scalable biomimetic SARS-CoV-2 nanovaccines with robust protective immune responsesChen, Xuenian; Shi, Tongfei; Yang, Chao*; Chen, Fangman; He, Xuan; Zhang, Kunbao; Hu, Hanze; Cai, Lulu; Leong, Kam W.*; Shao, Dan*Signal Transduction and Targeted Therapy, 2022, 7(1): 96.被引 6
期刊论文
Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines
8阅读
